BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35510179)

  • 1.
    Wei A; Lu X; Ma H; Lian H; Yang X; Zhang L; Wang D; Chen S; Zhang Q; Li Z; Zhang R; Yang J; Wang T
    Contrast Media Mol Imaging; 2022; 2022():4849081. PubMed ID: 35510179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Pre-therapeutic
    Lu X; Wei A; Yang X; Liu J; Li S; Kan Y; Wang W; Wang T; Zhang R; Yang J
    Front Med (Lausanne); 2021; 8():836438. PubMed ID: 35127776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of
    Yang X; Lu X; Liu J; Kan Y; Wang W; Zhang S; Liu L; Li J; Yang J
    Korean J Radiol; 2022 Apr; 23(4):466-478. PubMed ID: 35289150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis predicting value of semiquantitative parameters of visceral adipose tissue and subcutaneous adipose tissue of
    Liu J; Yang X; Yang J
    Ann Nucl Med; 2021 Mar; 35(3):386-396. PubMed ID: 33469854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
    Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
    Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
    [No Abstract]   [Full Text] [Related]  

  • 6. Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Mimicking Lymphoma on FDG PET/CT.
    Pan Q; Luo Y; Wu H; Ma Y; Li F
    Clin Nucl Med; 2018 Feb; 43(2):125-127. PubMed ID: 29215415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Value of
    Liang J; Cao H; Wu B; Liu Y; He Y; Xu B; Sun Y; Ye B; Lin J
    Front Immunol; 2021; 12():745211. PubMed ID: 34867971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis.
    Kim J; Yoo SW; Kang SR; Bom HS; Song HC; Min JJ
    Ann Hematol; 2014 Apr; 93(4):661-7. PubMed ID: 24061788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of
    Zheng Y; Hu G; Liu Y; Ma Y; Dang Y; Li F; Xing H; Wang T; Huo L
    Clin Radiol; 2016 Dec; 71(12):1248-1254. PubMed ID: 27387105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients.
    Yao S; He L; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
    Ann Med; 2023 Dec; 55(1):89-100. PubMed ID: 36533966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis simulating lymphadenitis on
    Lu J; Fang Q; Ma C; Su F; Chen G; Huang M; Wang W; Su X
    Hell J Nucl Med; 2017; 20(3):254-257. PubMed ID: 29177266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis.
    Zhang LJ; Xu J; Liu P; Ding CY; Li JY; Qiu HX; Zhang SJ
    J Hematol Oncol; 2012 Jul; 5():40. PubMed ID: 22824539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
    Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
    Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
    Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
    Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Yin Q; Wang J; Wang Z
    Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
    Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].
    Liu JH; Liu W; Li YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):575-580. PubMed ID: 37096536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.
    Huang J; Yin G; Duan L; Tian T; Xu J; Wang J; Gao X; Cheng W; Liu L; Qiu H
    J Clin Immunol; 2020 Jul; 40(5):718-728. PubMed ID: 32495220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective quality improvement initiative in adult hemophagocytic lymphohistiocytosis to improve testing and a framework to facilitate trigger identification and mitigate hemorrhage from retrospective analysis.
    Merrill SA; Naik R; Streiff MB; Shanbhag S; Lanzkron S; Braunstein EM; Moliterno AM; Brodsky RA
    Medicine (Baltimore); 2018 Aug; 97(31):e11579. PubMed ID: 30075527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific cytokine patterns in Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis compared to Kawasaki disease in children.
    Yang Y; Yu H; Li C; Gui Z; Chang Y
    Pediatr Hematol Oncol; 2023; 40(6):529-538. PubMed ID: 37178062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.